These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26136941)

  • 1. Impact of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene mutations.
    Wang T; Zhang T; Han X; Liu XI; Zhou N; Liu Y
    Exp Ther Med; 2015 Jun; 9(6):2095-2103. PubMed ID: 26136941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.
    Dong YJ; Cai YR; Zhou LJ; Su D; Mu J; Chen XJ; Zhang LI
    Oncol Lett; 2016 Apr; 11(4):2552-2558. PubMed ID: 27073516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
    Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
    Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between
    Bu L; Tu N; Wang K; Zhou Y; Xie X; Han X; Lin H; Feng H
    Korean J Radiol; 2022 Jan; 23(1):112-123. PubMed ID: 34983098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
    J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
    Cai Y; Chen T; Zhang S; Tan M; Wang J
    J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
    Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
    Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Dimensional Ground Glass Opacity Ratio in CT Images Can Predict Tumor Invasiveness of Stage IA Lung Cancer.
    Yu WS; Hong SR; Lee JG; Lee JS; Jung HS; Kim DJ; Chung KY; Lee CY
    Yonsei Med J; 2016 Sep; 57(5):1131-8. PubMed ID: 27401643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of EGFR mutation status with predominant histologic subtype of adenocarcinoma according to the new lung adenocarcinoma classification of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society.
    Villa C; Cagle PT; Johnson M; Patel JD; Yeldandi AV; Raj R; DeCamp MM; Raparia K
    Arch Pathol Lab Med; 2014 Oct; 138(10):1353-7. PubMed ID: 24571650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.
    Clay TD; Russell PA; Do H; Sundararajan V; Conron M; Wright GM; Dobrovic A; Moore MM; McLachlan SA
    Pathology; 2016 Jan; 48(1):17-24. PubMed ID: 27020204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma.
    Hu H; Pan Y; Li Y; Wang L; Wang R; Zhang Y; Li H; Ye T; Zhang Y; Luo X; Shao L; Sun Z; Cai D; Xu J; Lu Q; Deng Y; Shen L; Ji H; Sun Y; Chen H
    Onco Targets Ther; 2014; 7():1423-37. PubMed ID: 25152623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
    Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.
    Lin CY; Wu YM; Hsieh MH; Wang CW; Wu CY; Chen YJ; Fang YF
    PLoS One; 2017; 12(10):e0186567. PubMed ID: 29065153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the new IASLC/ATS/ERS proposed classification of adenocarcinoma based on lepidic pattern in patients with pathological stage IA pulmonary adenocarcinoma.
    Nakagiri T; Sawabata N; Morii E; Inoue M; Shintani Y; Funaki S; Okumura M
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):671-7. PubMed ID: 24890089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
    Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
    Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.